Single-cycle influenza virus vaccine generates lung CD8+ Trm that cross-react against viral variants and subvert virus escape mutants

Sci Adv. 2023 Sep 8;9(36):eadg3469. doi: 10.1126/sciadv.adg3469. Epub 2023 Sep 8.

Abstract

Influenza virus-specific tissue-resident memory (Trm) CD8+ T cells located along the respiratory tract provide cross-strain protection against a breadth of influenza viruses. We show that immunization with a single-cycle influenza virus vaccine candidate (S-FLU) results in the deposition of influenza virus nucleoprotein (NP)-specific CD8+ Trm along the respiratory tract that were more cross-reactive against viral variants and less likely to drive the development of cytotoxic T lymphocyte (CTL) escape mutants, as compared to the lung memory NP-specific CD8+ T cell pool established following influenza infection. This immune profile was linked to the limited inflammatory response evoked by S-FLU vaccination, which increased TCR repertoire diversity within the memory CD8+ T cell compartment. Cumulatively, this work shows that S-FLU vaccination evokes a clonally diverse, cross-reactive memory CD8+ T cell pool, which protects against severe disease without driving the virus to rapidly evolve and escape, and thus represents an attractive vaccine for use against rapidly mutating influenza viruses.

MeSH terms

  • CD8-Positive T-Lymphocytes
  • Humans
  • Immunization
  • Influenza Vaccines*
  • Influenza, Human* / prevention & control
  • Levonorgestrel
  • Lung
  • Nucleoproteins / genetics

Substances

  • Influenza Vaccines
  • Levonorgestrel
  • Nucleoproteins